Zhang Z - Search Results

1

Metabonomics reveals that triclocarban affects liver metabolism by affecting glucose metabolism, β-oxidation of fatty acids, and the TCA cycle in male mice.

Li W, Zhang W, Chang M, Ren J, Xie W, Chen H, Zhang Z, Zhuang X, Shen G, Li H. Li W, et al. Among authors: zhang w, zhang z. Toxicol Lett. 2018 Dec 15;299:76-85. doi: 10.1016/j.toxlet.2018.09.011. Epub 2018 Sep 24. Toxicol Lett. 2018. PMID: 30261223

2

Metabonomics Indicates Inhibition of Fatty Acid Synthesis, β-Oxidation, and Tricarboxylic Acid Cycle in Triclocarban-Induced Cardiac Metabolic Alterations in Male Mice.

Xie W, Zhang W, Ren J, Li W, Zhou L, Cui Y, Chen H, Yu W, Zhuang X, Zhang Z, Shen G, Li H. Xie W, et al. Among authors: zhang w, zhang z. J Agric Food Chem. 2018 Feb 14;66(6):1533-1542. doi: 10.1021/acs.jafc.7b05220. Epub 2018 Feb 5. J Agric Food Chem. 2018. PMID: 29364658

3

Quadrupole Orbitrap Mass Spectrometer-Based Metabonomic Elucidation of Influences of Short-Term Di(2-ethylhexyl) phthalate Exposure on Cardiac Metabolism in Male Mice.

Li W, Zhang W, Chang M, Ren J, Zhuang X, Zhang Z, Cui Y, Chen H, Xu B, Song N, Li H, Shen G. Li W, et al. Among authors: zhang w, zhang z. Chem Res Toxicol. 2018 Nov 19;31(11):1185-1194. doi: 10.1021/acs.chemrestox.8b00184. Epub 2018 Oct 17. Chem Res Toxicol. 2018. PMID: 30284816

4

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells.

Wu M, Zhao G, Zhuang X, Zhang T, Zhang C, Zhang W, Zhang Z. Wu M, et al. Among authors: zhang c, zhang w, zhang t, zhang z. Onco Targets Ther. 2018 May 18;11:2945-2954. doi: 10.2147/OTT.S165436. eCollection 2018. Onco Targets Ther. 2018. PMID: 29849464 Free PMC article.

5

A simplified model to predict P-glycoprotein interacting drugs from 3D molecular interaction field.

Zhuang XM, Xiao JH, Li JT, Zhang ZQ, Ruan JX. Zhuang XM, et al. Int J Pharm. 2006 Feb 17;309(1-2):109-14. doi: 10.1016/j.ijpharm.2005.11.009. Epub 2005 Dec 20. Int J Pharm. 2006. PMID: 16376035

6

Modification on the O-glucoside of Sergliflozin-A: A new strategy for SGLT2 inhibitor design.

Cao X, Zhang W, Yan X, Huang Z, Zhang Z, Wang P, Shen J. Cao X, et al. Among authors: zhang w, zhang z. Bioorg Med Chem Lett. 2016 May 1;26(9):2170-3. doi: 10.1016/j.bmcl.2016.03.065. Epub 2016 Mar 16. Bioorg Med Chem Lett. 2016. PMID: 27025345

7

Induction of CYP3A by morroniside in rats.

Xiong S, Li J, Zhang W, Wang X, Zhang Z. Xiong S, et al. Among authors: zhang w, zhang z. J Pharmacol Sci. 2015 Apr;127(4):414-8. doi: 10.1016/j.jphs.2015.02.014. Epub 2015 Mar 4. J Pharmacol Sci. 2015. PMID: 25953268 Free article.

8

Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction.

Liu F, Zhuang X, Yang C, Li Z, Xiong S, Zhang Z, Li J, Lu C, Zhang Z. Liu F, et al. Among authors: zhang z. Biopharm Drug Dispos. 2014 Jul;35(5):296-307. doi: 10.1002/bdd.1897. Epub 2014 Apr 13. Biopharm Drug Dispos. 2014. PMID: 24647883

9

P-Glycoprotein (ABCB1) limits the brain distribution of YQA-14, a novel dopamine D3 receptor antagonist.

Liu F, Wang X, Li Z, Li J, Zhuang X, Zhang Z. Liu F, et al. Among authors: zhang z. Chem Pharm Bull (Tokyo). 2015;63(7):512-8. doi: 10.1248/cpb.c15-00089. Chem Pharm Bull (Tokyo). 2015. PMID: 26133067 Free article.

10

The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.

Zhang W, Li Y, Zou P, Wu M, Zhang Z, Zhang T. Zhang W, et al. Among authors: zhang t, zhang z. AAPS J. 2016 Jul;18(4):830-43. doi: 10.1208/s12248-016-9928-8. Epub 2016 May 16. AAPS J. 2016. PMID: 27184579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102,357 results

Search Page